Rose Miranda1,2, Tinne Smets3,4, Nele Van Den Noortgate5, Jenny T van der Steen6,7, Luc Deliens3,4,8, Sheila Payne9, Katarzyna Szczerbińska10, Sophie Pautex11, Liesbeth Van Humbeeck5, Giovanni Gambassi12, Marika Kylänen13, Lieve Van den Block3,4. 1. Vrije Universiteit Brussel & Ghent University, End-of-Life Care Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium. rose.miranda@vub.be. 2. Vrije Universiteit Brussel, Department of Family Medicine and Chronic Care, Brussels, Belgium. rose.miranda@vub.be. 3. Vrije Universiteit Brussel & Ghent University, End-of-Life Care Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium. 4. Vrije Universiteit Brussel, Department of Family Medicine and Chronic Care, Brussels, Belgium. 5. Department of Geriatric Medicine, Ghent University Hospital, Ghent, Belgium. 6. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands. 7. Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam UMC-VU University Medical Center, Amsterdam, The Netherlands. 8. Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. 9. International Observatory on End-of-Life Care, Lancaster University, Lancaster, UK. 10. Laboratory for Research on Aging Society, Department of Sociology of Medicine, Epidemiology and Preventive Medicine Chair, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland. 11. Hôpitaux Universitaires de Genève, University of Geneva, Geneva, Switzerland. 12. Department of Internal Medicine, Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Rome, Italy. 13. National Institute for Health and Welfare, Helsinki, Finland.
Abstract
BACKGROUND: 'PACE Steps to Success' is a multicomponent training program aiming to integrate generalist and non-disease-specific palliative care in nursing homes. This program did not improve residents' comfort in the last week of life, but it appeared to improve quality of care and dying in their last month of life. Because this program included only three dementia-specific elements, its effects might differ depending on the presence or stage of dementia. We aimed to investigate whether the program effects differ between residents with advanced, non-advanced, and no dementia. METHODS: Pre-planned subgroup analysis of the PACE cluster-randomized controlled trial in 78 nursing homes in seven European countries. Participants included residents who died in the previous 4 months. The nursing home staff or general practitioner assessed the presence of dementia; severity was determined using two highly-discriminatory staff-reported instruments. Using after-death questionnaires, staff assessed comfort in the last week of life (Comfort Assessment in Dying-End-of-Life in Dementia-scale; primary outcome) and quality of care and dying in the last month of life (Quality of Dying in Long-Term Care scale; secondary outcome). RESULTS: At baseline, we included 177 residents with advanced dementia, 126 with non-advanced dementia and 156 without dementia. Post-intervention, respectively in the control and the intervention group, we included 136 and 104 residents with advanced dementia, 167 and 110 with non-advanced dementia and 157 and 137 without dementia. We found no subgroup differences on comfort in the last week of life, comparing advanced versus without dementia (baseline-adjusted mean sub-group difference 2.1; p-value = 0.177), non-advanced versus without dementia (2.7; p = 0.092), and advanced versus non-advanced dementia (- 0.6; p = 0.698); or on quality of care and dying in the last month of life, comparing advanced and without dementia (- 0.6; p = 0.741), non-advanced and without dementia (- 1.5; p = 0.428), and advanced and non-advanced dementia (0.9; p = 0.632). CONCLUSIONS: The lack of subgroup difference suggests that while the program did not improve comfort in dying residents with or without dementia, it appeared to equally improve quality of care and dying in the last month of life for residents with dementia (regardless of the stage) and those without dementia. A generalist and non-disease-specific palliative care program, such as PACE Steps to Success, is a useful starting point for future palliative care improvement in nursing homes, but to effectively improve residents' comfort, this program needs further development. TRIAL REGISTRATION: ISRCTN, ISRCTN14741671 . Registered 8 July 2015 - Retrospectively registered.
BACKGROUND: 'PACE Steps to Success' is a multicomponent training program aiming to integrate generalist and non-disease-specific palliative care in nursing homes. This program did not improve residents' comfort in the last week of life, but it appeared to improve quality of care and dying in their last month of life. Because this program included only three dementia-specific elements, its effects might differ depending on the presence or stage of dementia. We aimed to investigate whether the program effects differ between residents with advanced, non-advanced, and no dementia. METHODS: Pre-planned subgroup analysis of the PACE cluster-randomized controlled trial in 78 nursing homes in seven European countries. Participants included residents who died in the previous 4 months. The nursing home staff or general practitioner assessed the presence of dementia; severity was determined using two highly-discriminatory staff-reported instruments. Using after-death questionnaires, staff assessed comfort in the last week of life (Comfort Assessment in Dying-End-of-Life in Dementia-scale; primary outcome) and quality of care and dying in the last month of life (Quality of Dying in Long-Term Care scale; secondary outcome). RESULTS: At baseline, we included 177 residents with advanced dementia, 126 with non-advanced dementia and 156 without dementia. Post-intervention, respectively in the control and the intervention group, we included 136 and 104 residents with advanced dementia, 167 and 110 with non-advanced dementia and 157 and 137 without dementia. We found no subgroup differences on comfort in the last week of life, comparing advanced versus without dementia (baseline-adjusted mean sub-group difference 2.1; p-value = 0.177), non-advanced versus without dementia (2.7; p = 0.092), and advanced versus non-advanced dementia (- 0.6; p = 0.698); or on quality of care and dying in the last month of life, comparing advanced and without dementia (- 0.6; p = 0.741), non-advanced and without dementia (- 1.5; p = 0.428), and advanced and non-advanced dementia (0.9; p = 0.632). CONCLUSIONS: The lack of subgroup difference suggests that while the program did not improve comfort in dying residents with or without dementia, it appeared to equally improve quality of care and dying in the last month of life for residents with dementia (regardless of the stage) and those without dementia. A generalist and non-disease-specific palliative care program, such as PACE Steps to Success, is a useful starting point for future palliative care improvement in nursing homes, but to effectively improve residents' comfort, this program needs further development. TRIAL REGISTRATION: ISRCTN, ISRCTN14741671 . Registered 8 July 2015 - Retrospectively registered.
Entities:
Keywords:
Bereavement; Communication; End of life care; Neurological conditions; Nursing home care; Pain
Authors: Jean C Munn; Sheryl Zimmerman; Laura C Hanson; Christianna S Williams; Philip D Sloane; Elizabeth C Clipp; James A Tulsky; Karen E Steinhauser Journal: J Am Geriatr Soc Date: 2007-09 Impact factor: 5.562
Authors: Mirjam C van Soest-Poortvliet; Jenny T van der Steen; Sheryl Zimmerman; Lauren W Cohen; David Reed; Wilco P Achterberg; Miel W Ribbe; Henrica C W de Vet Journal: J Am Med Dir Assoc Date: 2012-11-17 Impact factor: 4.669
Authors: Lara Pivodic; Tinne Smets; Nele Van den Noortgate; Bregje D Onwuteaka-Philipsen; Yvonne Engels; Katarzyna Szczerbińska; Harriet Finne-Soveri; Katherine Froggatt; Giovanni Gambassi; Luc Deliens; Lieve Van den Block Journal: Palliat Med Date: 2018-10-01 Impact factor: 4.762
Authors: Lieve Van den Block; Elisabeth Honinx; Lara Pivodic; Rose Miranda; Bregje D Onwuteaka-Philipsen; Hein van Hout; H Roeline W Pasman; Mariska Oosterveld-Vlug; Maud Ten Koppel; Ruth Piers; Nele Van Den Noortgate; Yvonne Engels; Myrra Vernooij-Dassen; Jo Hockley; Katherine Froggatt; Sheila Payne; Katarzyna Szczerbinska; Marika Kylänen; Giovanni Gambassi; Sophie Pautex; Catherine Bassal; Stefanie De Buysser; Luc Deliens; Tinne Smets Journal: JAMA Intern Med Date: 2020-02-01 Impact factor: 21.873
Authors: Tinne Smets; Bregje B D Onwuteaka-Philipsen; Rose Miranda; Lara Pivodic; Marc Tanghe; Hein van Hout; Roeline H R W Pasman; Mariska Oosterveld-Vlug; Ruth Piers; Nele Van Den Noortgate; Anne B Wichmann; Yvonne Engels; Myrra Vernooij-Dassen; Jo Hockley; Katherine Froggatt; Sheila Payne; Katarzyna Szczerbińska; Marika Kylänen; Suvi Leppäaho; Ilona Barańska; Giovanni Gambassi; Sophie Pautex; Catherine Bassal; Luc Deliens; Lieve Van den Block Journal: BMC Palliat Care Date: 2018-03-12 Impact factor: 3.234
Authors: Katherine A Froggatt; Danni Collingridge Moore; Lieve Van den Block; Julie Ling; Sheila A Payne Journal: J Am Med Dir Assoc Date: 2020-02-28 Impact factor: 4.669